Your browser doesn't support javascript.
loading
Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.
Tiwari, Arun K; Zai, Clement C; Altar, C Anthony; Tanner, Julie-Anne; Davies, Paige E; Traxler, Paul; Li, James; Cogan, Elizabeth S; Kucera, Matthew T; Gugila, Ana; Braganza, Nicole; Emmerson, Heather; Zai, Gwyneth; Müller, Daniel J; Levitan, Robert; Kloiber, Stefan; Daskalakis, Zafiris J; Frey, Benicio N; Bowen, James M; Tarride, Jean-Eric; Tytus, Richard; Chandrasena, Ranjith; Voudouris, Nicholas; Taylor, Valerie H; Tempier, Raymond; Sharma, Verinder; Vasudev, Akshya; Dzongowski, Peter; Pliamm, Lew; Greenspoon, Todd; Dechairo, Bryan M; Kennedy, James L.
Afiliación
  • Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Zai CC; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Altar CA; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Tanner JA; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Davies PE; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Traxler P; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Li J; Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA.
  • Cogan ES; Myriad Neuroscience, Mason, OH, USA.
  • Kucera MT; Myriad Neuroscience, Mason, OH, USA.
  • Gugila A; Myriad Neuroscience, Mason, OH, USA.
  • Braganza N; Myriad Neuroscience, Mason, OH, USA.
  • Emmerson H; Myriad Genetics, Salt Lake City, UT, USA.
  • Zai G; Myriad Genetics, Salt Lake City, UT, USA.
  • Müller DJ; Myriad Neuroscience, Mason, OH, USA.
  • Levitan R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Kloiber S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Daskalakis ZJ; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Frey BN; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Bowen JM; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Tarride JE; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Tytus R; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Chandrasena R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Voudouris N; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Taylor VH; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Tempier R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Sharma V; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Vasudev A; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Dzongowski P; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Pliamm L; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Greenspoon T; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Dechairo BM; Department of Psychiatry, UC San Diego, San Diego, CA, USA.
  • Kennedy JL; Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
Transl Psychiatry ; 12(1): 214, 2022 May 30.
Article en En | MEDLINE | ID: mdl-35637185
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Transl Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Transl Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Canadá